Table 2

Characteristics of patient cohort with complications

Patient noAneurysm locationAneurysm size (mm)Age (years)HTNDiabetesHyper-lipidemiaTobacco useCoronary artery diseaseAntiplatelet usedStent useIntra-procedural complicationAneurysm size >2 cm
1Superior hypophyseal16×13×1050sYNYNNASA+clopidogrelYNN
2Ophthalmic5×7×750sNNNNNASA+clopidogrelNNN
3Vertebral sidewall10×11×1070sNNNYNASA+clopidogrelYNN
4Basilar apex8×6×570sYNYYNASA+clopidogrelNNN
5Basilar apex30×28×2220sNNNNNASA aloneYNY
6Ophthalmic22×16×1460sYNYYNASA+clopidogrelNNY
7Posterior communicating artery8×6×550sYNNYYASA+clopidogrelYYN
8Ophthalmic4×4×570sYNNYNASA+clopidogrelYNN
9Basilar apex5×4×340sYNNYNASA+clopidogrelYYN
10Ophthalmic2×3×440sYNNYNASA+clopidogrelNYN
11Basilar apex21×14×1670sYNYYNASA+clopidogrelYYY
  • ASA, aspirin; HTN, hypertension.